Consistent with this assumption, our results revealed that the low expression level of MHC genes through which DCs present the tumor antigen to T cells [43], [48], in tumor tissues was also independently prognostic of poor survival in NSCLC patients. The gene discussed is HLA-C; the disease is non-small cell lung carcinoma.